J1555 Injection, immune globulin (cuvitru), 100 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Inj cuvitru, 100 mg
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, immune globulin (cuvitru), 100 mg | yes |
Related codes in J15
- J1551 Injection, immune globulin (cutaquig), 100 mg
- J1552 Injection, immune globulin (alyglo), 500 mg
- J1553 Injection, immune globulin (yimmugo), 100 mg
- J1554 Injection, immune globulin (asceniv), 500 mg
- J1556 Injection, immune globulin (bivigam), 500 mg
- J1557 Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558 Injection, immune globulin (xembify), 100 mg
- J1559 Injection, immune globulin (hizentra), 100 mg
- J1560 Injection, gamma globulin, intramuscular, over 10 cc
- J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1566 Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
- J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1569 Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
- J1570 Injection, ganciclovir sodium, 500 mg
- J1571 Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
- J1572 Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1573 Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
- J1574 Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
- J1575 Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
- J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg